Asahi Kasei Corporation (TYO:3407)
1,304.00
+8.00 (0.62%)
At close: Nov 28, 2025
Asahi Kasei Revenue
Asahi Kasei had revenue of 748.05B JPY in the quarter ending September 30, 2025, a decrease of -0.84%. This brings the company's revenue in the last twelve months to 3.03T, up 3.55% year-over-year. In the fiscal year ending March 31, 2025, Asahi Kasei had annual revenue of 3.04T with 9.06% growth.
Revenue (ttm)
3.03T
Revenue Growth
+3.55%
P/S Ratio
0.58
Revenue / Employee
60.24M
Employees
50,352
Market Cap
1.77T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 3.04T | 252.43B | 9.06% |
| Mar 31, 2024 | 2.78T | 58.39B | 2.14% |
| Mar 31, 2023 | 2.73T | 265.17B | 10.77% |
| Mar 31, 2022 | 2.46T | 355.27B | 16.87% |
| Mar 31, 2021 | 2.11T | -45.60B | -2.12% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nippon Steel | 8.95T |
| JFE Holdings | 4.64T |
| Mitsubishi Chemical Group | 3.96T |
| Shin-Etsu Chemical | 2.58T |
| AGC Inc. | 2.05T |
| Nippon Paint Holdings | 1.73T |
| Sumitomo Metal Mining | 1.58T |
| Resonac Holdings | 1.35T |
Asahi Kasei News
- 15 days ago - Asahi Kasei Wins BioTech Breakthrough Award for Planova™ FG1 Filter - Business Wire
- 16 days ago - Asahi Kasei Microdevices Showcases AgeTech and PetTech Solutions Combining Privacy and Convenience at CES® 2026 - Business Wire
- 24 days ago - Asahi Kasei H1 Profit Improves, But Sales Drop; Revises Guidance - Nasdaq
- 24 days ago - Asahi Kasei Licenses Novel Electrolyte Technology to EAS Batteries for the Market Launch of an Ultra-High-Power Cell - Business Wire
- 24 days ago - Nefecon Included in the Updated KDIGO Clinical Practice Guideline, Strengthening Asahi Kasei's Position in IgA Nephropathy Treatment - Business Wire
- 5 weeks ago - Asahi Kasei Expanding Capacity to Manufacture System Components for Clean Hydrogen - Business Wire
- 7 weeks ago - Asahi Kasei Expands Healthcare Materials Portfolio with Sonanos™ Next-Generation Excipients - Business Wire
- 7 weeks ago - Asahi Kasei Elevates Critical Care Solutions with FDA Approval of ZOLL's Zenix Monitor/Defibrillator - Business Wire